![](/img/cover-not-exists.png)
The development of a potent, KDR/VEGFR2-sparing RET kinase inhibitor for treating patients with RET-dependent cancers
Brandhuber, B., Haas, J., Tuch, B., Ebata, K., Bouhana, K., McFaddin, E., Williams, L., Winski, S., Brown, E., Burkhard, M., Nanda, N., Hamor, R., Sullivan, F., Hanson, L., Morales, T., Vigers, G., WaVolume:
69
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)33028-3
Date:
December, 2016
File:
PDF, 51 KB
english, 2016